Comparison of analgesic effects between naproxen and diclofenac in randomized controlled trials
Lao Zhi, Yang Hu, Xia Liu
Abstract
Lao Zhi, Yang Hu, Xia Liu
Abstract
Naproxen 2mL (0.2g) or diclofenac 2mL (50mg) was injected im to 170 patients with rheumatoid arthritis bid, for 14 d, and qd or bid to 70 women with dysmenorrhea and 72 patients with postoperative pain for randomized double-blind trials. Results showed no significant difference between the analgesic effects of the 2 drugs (P0. 05). Severe pain at the im site was complained by 43% and 42% of the patients after naproxen and diclofenac, respectively.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Naproxen 2mL (0.2g) or diclofenac 2mL (50mg) was injected im to 170 patients with rheumatoid arthritis bid, for 14 d, and qd or bid to 70 women with dysmenorrhea and 72 patients with postoperative pain for randomized double-blind trials. Results showed no significant difference between the analgesic effects of the 2 drugs (P0. 05). Severe pain at the im site was complained by 43% and 42% of the patients after naproxen and diclofenac, respectively.
Key concepts: Naproxen, Diclofenac, Analgesic, Medicine, Rheumatoid arthritis, Anesthesia, Randomized controlled trial, Single blind